Records containing: Solid Tumors
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2012-10-18A Multi-Arm Complete Phase 1 Trial of Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor
-
CLINICAL_TRIALS study record update · 2012-10-18Phase I Dose Escalating Study Of Tas-106 In Combination With Carboplatin In Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-10-12A Multi-center, Open-Label, Extension Study of ALN-VSP02 in Cancer Patients Who Have Responded to ALN-VSP02 Treatment
-
CLINICAL_TRIALS study record update · 2012-08-01A Phase I Study of a Novel Chemotherapeutic Regimen: Topotecan, Ifosfamide and Carboplatin (TIC) in Children and Young Adults With Solid Tumors-- A Limited Multi-Institution Study
-
CLINICAL_TRIALS study record update · 2012-08-01Phase I Trial of ZIO-101 in Patients With Solid Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-07-31A Phase I Study of Doxercalciferol in Recurrent Pediatric Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-07-30Clinical Study Protocol RTA 402-C-0501: A Phase I Dose-finding and Pharmacokinetic Study of RTA 402 (CDDO-Me) Administered Orally for 21 Days of a 28-day Cycle in Patients With Advanced Solid Tumors or Lymphoid Malignancies
-
CLINICAL_TRIALS study record update · 2012-07-24An Open-label, Single-dose, Randomized, Crossover Study to Determine the Effects of Food on the Pharmacokinetics of Tesetaxel 10 mg Capsule in Solid Tumor Cancer Subjects
-
CLINICAL_TRIALS study record update · 2012-07-19Dose-finding and Pharmacokinetic Trial of Orally Administered D-24851 to Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-07-19IBL1002:Phase I Study of Indibulin in Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-07-19A Phase I Trial of ZIO-101 in Solid Tumors: Protocol # SGL1002
-
CLINICAL_TRIALS study record update · 2012-07-11A Phase I/II, Open-Label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the Tor Kinase Inhibitor AZD8055 Administered Orally to Patients With Advanced Solid Tumours.
-
CLINICAL_TRIALS study record update · 2012-06-28A Phase I Study of MK-4827 in Patients With Solid Tumor
-
CLINICAL_TRIALS study record update · 2012-06-12A Phase 1, Open Label, Multi-Center, Accelerated Dose-Escalation, Pharmacokinetic And Pharmacodynamic Trial Of The Oral Single Agent Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid Tumors For Whom No Standard Therapy Is Available
-
CLINICAL_TRIALS study record update · 2012-05-15A Phase 1 Trial of Escalating Doses of Karenitecin Plus Cyclophosphamide Administered Intravenously Daily for 5 Consecutive Days in Pediatric Patients With Refractory or Recurrent Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-05-02A Phase 1, Open Label, Dose Escalation Study Evaluating the Safety and Pharmacokinetics of Enteric Coated D-3263 Hydrochloride in Subjects With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-04-25An Open Label Phase I Study to Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension)
-
CLINICAL_TRIALS study record update · 2012-04-23A Phase I Dose Escalation Study of Oral SB939 When Administered Thrice Weekly (Every Other Day) for 3 Weeks in a 4-week Cycle in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2012-04-06A Safety, Pharmacokinetic, and Pharmacodynamic Assessment of Genasense Administered as a 2-hour Intravenous Infusion to Subjects With Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-04-04A Phase 1, Multi-center, Open-label, Dose-escalation, Safety, Pharmacodynamic and Pharmacokinetic Study of EP-100 Given Intravenously 3 Out of 4 Weeks in Subjects With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-03-28Phase I Study of the Combination of Temsirolimus (CCI-779) and Pazopanib (GW786034) in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-03-28Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle
-
CLINICAL_TRIALS study record update · 2012-03-06A Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-01-31A Multi-Center, Open-Label, Single-Arm, Phase 1, Dose Escalation Study of ASONEP (Sonepcizumab/LT1009) Administered as a Single Agent Weekly to Subjects With Refractory Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-01-13HLA-haploidentical Allogeneic Hematopoietic Cell Transplantation Using CD3 Depletion for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors After Conditioning of TBI, Fludarabine, Cyclophosphamide and Antithymocyte Globulin